Clinical Trials · NCT01818648
Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
- Phase
- Phase 4
- Recruitment status
- Withdrawn
- Sponsor
- Mayo Clinic
- Enrollment
- 0
- Start date
- Mar 2013
- Locations
- See registry
- Primary endpoint
- Change in 24hr Gastrointestinal and Colonic Transit before and after Exenatide vs placebo